Large-scale multiplex polymerase chain reaction assay for diagnosis of viral reactivations after allogeneic hematopoietic stem cell transplantation

Journal of Medical Virology

Volumn 87, Issue 8, 2015, Pages 1427-1435

  Inazawa, Natsuko ^a   Hori, Tsukasa ^a   Hatakeyama, Naoki ^a   Yamamoto, Masaki ^a   Yoto, Yuko ^a   Nojima, Masanori ^a   Suzuki, Nobuhiro ^b   Shimizu, Norio ^c   Tsutsumi, Hiroyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO MEDICAL CENTER   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Hematopoietic stem cell transplantation; Multiplex polymerase chain reaction; Viral reactivation

Indexed keywords

CYCLOSPORIN; GENOMIC DNA; MYCOPHENOLATE MOFETIL; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS DNA;

ADENOVIRIDAE; ADOLESCENT; ADULT; AGE; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BK VIRUS; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; GRAFT VERSUS HOST REACTION; HEPATITIS B VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HLA MATCHING; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; HUMAN PARVOVIRUS B19; INFANT; JC VIRUS; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PROSPECTIVE STUDY; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS REACTIVATION; ADVERSE EFFECTS; ALLOTRANSPLANTATION; EVALUATION STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOCOMPROMISED PATIENT; MIDDLE AGED; MOLECULAR DIAGNOSIS; PRESCHOOL CHILD; PROCEDURES; VIRUS ACTIVATION; VIRUS DISEASES; YOUNG ADULT;

ADENOVIRIDAE; BK POLYOMAVIRUS; CYTOMEGALOVIRUS; HEPATITIS B VIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; HUMAN HERPESVIRUS 8; JC POLYOMAVIRUS; PARVOVIRUS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIPLEX POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION; VIRUS DISEASES; YOUNG ADULT;

EID: 84930373495     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24161     Document Type: Article

References (23)

1. Appleton AL, Sviland L, Peiris JS, Taylor CE, Wilkes J, Green MA, Pearson AD, Kelly PJ, Malcolm AJ, Proctor SJ. 1995. Human herpes virus-6 infection in marrow graft recipients: Role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group. Bone Marrow Transplant 16:777-782.
2. Betts BC, Young JA, Ustun C, Cao Q, Weisdorf DJ. 2011. Human herpes virus 6 infection after hematopoietic cell transplantation: Is routine surveillance necessary?. Biol Blood Marrow Transplant 17:1562-1568.
3. Burgart LJ, Robinson RA, Heller MJ, Wilke WW, Iakoubova OK, Cheville JC. 1992. Multiplex polymerase chain reaction. Mod Pathol 5:320-323.
4. Chevallier P, Hebia-Fellah I, Planche L, Guillaume T, Bressolette-Bodin C, Coste-Burel M, Rialland F, Mohty M, Imbert-Marcille BM. 2010. Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: A comparison with matched unrelated donors as stem cell source. Bone Marrow Transplant 45:1204-1211.
5. Curtis RE, Travis LB, Rowlings PA, Socie G, Kingma DW, Banks PM, Jaffe ES, Sale GE, Horowitz MM, Witherspoon RP, Shriner DA, Weisdorf DJ, Kolb HJ, Sullivan KM, Sobocinski KA, Gale RP, Hoover RN, Fraumeni JF, Jr., Deeg HJ. 1999. Risk of lymph proliferative disorders after bone marrow transplantation: A multi-institutional study. Blood 94:2208-2216.
6. Dbaugnies F, Busson L, Ferster A, Lewalle P, Azzi N, Aoun M, Verhaegen G, Mahadeb B, de Marchin J, Vandenberg O, Hallin M. 2014. Detection of herpesviridae in whole blood by multiplex PCR DNA-based microarray analysis after hematopoietic stem cell transplantation. J Clin Microbiol 52:2552-2556.
7. de Pagter PJ, Schuurman R, Visscher H, de Vos M, Bierings M, van Loon AM, Uiterwaal CS, van Baarle D, Sanders EA, Boelens J. 2008. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: An important risk factor for clinical outcome. Biol Blood Marrow Transplant 14:831-839.
8. Dulery R, Salleron J, Dewilde A, Rossignol J, Boyle EM, Gay J, de Berranger E, Coiteux V, Jouet JP, Duhamel A, Yakoub-Agha I. 2012. Early human herpes virus type 6 reactivation after allogeneic stem cell transplantation: A large-scale clinical study. Biol Blood Marrow Transplant 18:1080-1089.
9. George B, Pati N, Gilroy N, Ratnamohan M, Huang G, Kerridge I, Hertzberg M, Gottlieb D, Bradstock K. 2010. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy. Transpl Infect Dis 12:322-329.
10. Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW, Takahashi TA, Ortega J, Filipovich A, Locatelli F, Asano S, Fagioli F, Vowels M, Sirvent A, Laporte JP, Tiedemann K, Amadori S, Abecassis M, Bordigoni P, Diez B, Shaw PJ, Vora A, Caniglia M, Garnier F, Ionescu I, Garcia J, Koegler G, Rebulla P, Chevret S, Eurocord Group . 2004. Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice. Exp Hematol 32:397-407.
11. Guimaraes AL, Gomes CC, da Silva LM, Correia-Silva Jde, Victoria F, Gomez JM, Bittencourt RS. 2009. Association between oral HSV-1 and survival in allogeneic hematopoietic stem cell transplanted patients. Med Oral Patol Oral Cir Bucal 14:E62-E68.
12. Jaskula E, Dlubek D, Sedzimirska M, Duda D, Tarnowska A, Lange A. 2010. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation. Transplant Proc 42:3273-3276.
13. Kalpoe JS, van der Heiden PL, Barge RM, Houtzager S, Lankester AC, van Tol MJ, Kroes AC. 2007. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning. Eur J Haematol 78:314-321.
14. Lu Y, Wu T, Cao XY, Wang JB, Sun Y, Zhao YL, Ji WM, Tong SQ, Lu CR. 2011. Monitoring of early Epstein-Barr virus reactivation and preemptive therapy after allogeneic hematopoietic stem cell transplantation. Zhonghua Nei Ke Za Zhi 50:383-387.
15. Lusso P. 2006. HHV-6 and the immune system: Mechanisms of immunomodulation and viral escape. J Clin Virol 37:S4-10.
16. O'Donnell PH, Swanson K, Josephson MA, Artz AS, Parsad SD, Ramaprasad C, Pursell K, Rich E, Stock W, van Besien K. 2009. BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoietic stem cell transplants. Biol Blood Marrow Transplant 15:1038-1048.e1.
17. Ogata M, Kikuchi H, Satou T, Kawano R, Ikeuchi J, Kohno K, Kashima K, Ohtsuka E, Kadota J. 2006. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: Incidence and clinical significance. J Infect Dis 193:68-79.
18. Peric Z, Cahu X, Chevallier P, Brissot E, Malard F, Guillaume T, Delaunay J, Ayari S, Dubruille V, Le Gouill S, Mahe B, Gastinne T, Blin N, Saulquin B, Harousseau JL, Moreau P, Milpied N, Coste-Burel M, Imbert-Marcille BM, Mohty M. 2011. Features of Epstein-Barr virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation. Leukemia 25:932-938.
19. Sashihara J, Tanaka-Taya K, Tanaka S, Amo K, Miyagawa H, Hosoi G, Taniguchi T, Fukui T, Kasuga N, Aono T, Sako M, Hara J, Yamanishi K, Okada S. 2002. High incidence of human herpes virus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 100:2005-2011.
20. Tomaszewska A, Krysko A, Dzieciatkowski T, Przybylski M, Basak GW, Halaburda K, Piekarska K, Sulowska A, Nasilowska-Adamska B, Mlynarczyk G, Jedrzejczak WW, Marianska B. 2014. Co-infections with cytomegalovirus and human herpes virus type 7 in adult Polish allogeneic hematopoietic stem cell transplant recipients. Arch Immunol Ther Exp (Warsz) 62:77-80.
21. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NK, Davies SM. 2002. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611-1618.
22. Zawilinska B, Kopec J, Szostek S, Piatkowska-Jakubas B, Skotnicki AB, Kosz-Vnenchak M. 2011. Lymph tropic herpes virus DNA detection in patients with active CMV infection-A possible role in the course of CMV infection after hematopoietic stem cell transplantation. Med Sci Monit 17:CR432-CR441.
23. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. 2005. Clinical outcomes of human herpes virus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 40:932-940.